Basilea Pharmaceutica's total assets for Q4 2024 were CHF257.76M, an increase of 36.63% from the previous quarter. CH:BSLN total liabilities were CHF176.76M for the fiscal quarter, a 2.84% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.